Centre Hospitalier de Valence ( Site 0377)
Valence, Drome 26953
0 studies enrolling now · 1 studies all time
What they study most
Carcinoma, Squamous Cell
Studies at this site
Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)
— Completed